Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease
about
Biomarkers of intestinal fibrosis - one step towards clinical trials for stricturing inflammatory bowel diseaseGenetic and epigenetic regulation of intestinal fibrosisGenetic Influences on the Development of Fibrosis in Crohn's DiseaseNew insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel diseaseThe behavior of matrix metalloproteinases and their inhibitors in colorectal cancerMatrix metalloproteinases in inflammatory bowel disease: an updateAssociation between TNF-alpha and Entamoeba histolytica diarrheaLipid alterations in experimental murine colitis: role of ceramide and imipramine for matrix metalloproteinase-1 expression.Genetic evidence supporting the association of protease and protease inhibitor genes with inflammatory bowel disease: a systematic reviewPPARα-dependent exacerbation of experimental colitis by the hypolipidemic drug fenofibrate.Identification of matrix metalloproteinase-2 and -9 activities within intestinal mucosa of clinically healthy beagle dogsTissue inhibitor of metalloproteinase 1 is preferentially expressed in Th1 and Th17 T-helper cell subsets and is a direct STAT target gene.Active matrix metalloprotease-9 is associated with the collagen capsule surrounding the Madurella mycetomatis grain in mycetoma.Results of the 4th scientific workshop of the ECCO (I): pathophysiology of intestinal fibrosis in IBD.Differential expression of extracellular matrix components in the Fallopian tubes throughout the menstrual cycle.Tumor necrosis factor alpha-308 gene polymorphism and pseudoexfoliation glaucoma.Crohn's disease complicated by strictures: a systematic review.The 372 T/C genetic polymorphism of TIMP-1 is associated with serum levels of TIMP-1 and survival in patients with severe sepsis.Increased Expression of Matrix Metalloproteinase-1 and 3 in Remission Patients of Steroid-Dependent Ulcerative Colitis.TNF-alpha gene polymorphisms in Iranian Azari Turkish patients with inflammatory bowel diseases.The sex bias in systemic sclerosis: on the possible mechanisms underlying the female disease preponderance.Results of the 4th scientific workshop of the ECCO (Group II): markers of intestinal fibrosis in inflammatory bowel disease.Impact of proteolytic enzymes in colorectal cancer development and progression.The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases.Role of matrix metalloproteinases in the pathogenesis of childhood gastroenteritis.Evaluation of genetic polymorphisms in clusterin and tumor necrosis factor-alpha genes in South Indian individuals with pseudoexfoliation syndrome.A local imbalance between MMP and TIMP may have an implication on the severity and course of appendicitis.Cellular and molecular mechanisms of intestinal fibrosis.Protective role of metalloproteinase inhibitor (AE-941) on ulcerative colitis in rats.NF-kappaB and ZBP-89 regulate MMP-3 expression via a polymorphic site in the promoter.High-sensitivity C-reactive Protein and Tumor Necrosis Factor Alpha in Pseudoexfoliation Syndrome.Changes in matrix metalloproteinase (MMP) and tissue inhibitors of metalloproteinases (TIMP) expression profile in Crohn's disease after immunosuppressive treatment correlate with histological score and calprotectin values.Correlation between serum matrix metalloproteinase and antigenemia levels in patients infected with rotavirus.Association of TIMP-1 and TIMP-2 gene polymorphisms with progression of liver fibrosis in patients with type C chronic liver disease.MMP-2 is a disease-modifying gene in primary sclerosing cholangitis.Use of serum biomarkers in a diagnostic test for irritable bowel syndrome.Elevated levels of plasma tumor necrosis factor alpha in patients with pseudoexfoliation glaucoma.Gene polymorphisms of the MMP1, MMP9, MMP12, IL-1β and TIMP1 and the risk of primary open-angle glaucoma.Host single nucleotide polymorphisms of MMP-9 -1562/TIMP-1 372 have gender differences in the risk of gastric intestinal metaplasia after Helicobacter pylori infection.The Impact of Matrix Metalloproteinases and Their Tissue Inhibitors in Inflammatory Bowel Diseases
P2860
Q26740542-EE8826B7-612D-4959-9652-C2BB213C57D6Q26740553-21FA800F-59FF-42DD-B726-04E82E67BB02Q26745889-D7C84F8C-B809-4629-936F-9D1D0FCE6CE8Q26851490-752C2858-83D5-4480-8868-51DE67263479Q27004958-8CE67789-ED95-4340-A138-4458255D3EFBQ28080664-C997EF62-4F36-4AF1-974F-B34DD9D2C6E8Q30432798-862F1B28-1236-4FB4-A512-36D73D2DCD7FQ33507287-54A08F32-101A-4607-9AE1-A64B8CB57188Q34023277-71CF907A-D530-4F41-A455-CBA8BF58F302Q34131110-E8581AF0-AFF1-423F-B408-0CEDE322898DQ34136570-94C82312-53C2-4A50-A4AA-2DBF57E4E4AFQ34651167-718FCBC2-8486-4595-8694-C27302F5806BQ35133359-02A51FC4-FACF-4012-A25D-C5F18EB0D0E6Q35147482-4190E0F0-B9A7-42FE-88DC-69DFD789E8DDQ36373415-9203AC6C-38F6-4A6D-B5B0-4CC511285F51Q36932595-1E5FBB35-D8C6-424D-857E-4A577E9452AEQ36945422-A8B7424C-3295-4A19-AD9C-ADD317A5D4C6Q36997866-1245AAC1-3626-4A65-A5B1-357F0DE53821Q37477606-A01BB813-8264-4616-8277-9C89C3038E31Q37703499-736CE84C-EADA-470E-A406-3E213BA54FB2Q38152687-0084B8F0-4B00-40F4-99F7-C21C02D5ADF1Q38204104-28F697BE-3BF9-45F7-9689-37FDCC86F5A3Q38259533-63424C41-CF0D-4239-A9A3-0EFD5C5FC8CAQ38881849-38384421-9628-4E67-AC23-754FF8DD8C7AQ40833901-0A78820E-3DAF-434B-B93E-D604FC650842Q41105470-CC819AAF-2801-4B1D-B894-CAF578D85B30Q42004360-72547687-F930-453E-98B1-75F177750E19Q42252132-E0B1DEA2-8DFD-4651-B148-9D8CC8E21A45Q42430941-3F70E9D0-88B0-4234-949D-A2FB13FA6C20Q43132243-F6B4B1B9-01F3-4B41-8CE2-FCF90E31A850Q43143286-2E18ED7A-D665-4199-ABBE-E80A80A75EE1Q43298991-55270817-4E66-430F-B2A9-285CE724E74FQ43712767-26CABA24-FB9C-4448-B5C2-3F16AD8C285BQ43742587-F3AC3F57-813B-4EBB-AD56-A69428159C05Q46214642-2397D364-F3C1-411E-B575-1E6BD33A2329Q48737767-DD13C3FB-0B46-4434-9C5B-B58A74B4B2F8Q49337447-70BF289F-BD10-4608-939B-B5BE22AEEB62Q50879206-0102E96A-9C0F-41BC-BBE4-EBEB2405C63AQ54456030-5002B42E-FF67-4FED-A848-9812DDBC14A2Q58427369-8E401FB8-8E2D-4D46-8F08-5E677F3DF878
P2860
Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Role of matrix metalloproteina ...... in inflammatory bowel disease
@ast
Role of matrix metalloproteina ...... in inflammatory bowel disease
@en
Role of matrix metalloproteina ...... in inflammatory bowel disease
@nl
type
label
Role of matrix metalloproteina ...... in inflammatory bowel disease
@ast
Role of matrix metalloproteina ...... in inflammatory bowel disease
@en
Role of matrix metalloproteina ...... in inflammatory bowel disease
@nl
prefLabel
Role of matrix metalloproteina ...... in inflammatory bowel disease
@ast
Role of matrix metalloproteina ...... in inflammatory bowel disease
@en
Role of matrix metalloproteina ...... in inflammatory bowel disease
@nl
P2093
P2860
P356
P1476
Role of matrix metalloproteina ...... in inflammatory bowel disease
@en
P2093
Cornelis B H W Lamers
Daniel W Hommes
Hein W Verspaget
Marij A C Mieremet-Ooms
Martin J W Meijer
Ruud A van Hogezand
P2860
P304
P356
10.3748/WJG.V13.I21.2960
P407
P577
2007-06-01T00:00:00Z